Presentations

• November 10, 2018
  

  Comparability of a Provisioned Device Versus Bring Your Own Device for Completion of Patient-Reported Outcome (PRO) Measures by Participants with Chronic Obstructive Pulmonary Disease (COPD): Quantitative Interview Findings

• July 12, 2018
  

  Hippocampal Volume as an Enrichment Biomarker in Trials of Patients with Mild Cognitive Impairment

• July 12, 2018
  

  Facilitating rapid data and information sharing by establishing a sustainable, integrated, and standardized platform advancing knowledge to enable expedited drug development

• June 28, 2018
  

  Parent Project Muscular Dystrophy (PPMD) 2018 Annual Conference

  Jane Larkindale, Executive Director of D-RSC, attended the Parent Project Muscular Dystrophy (PPMD) 2018 Annual Conference in Scottsdale, AZ on June 28 – July 1.  She participated on a panel, Today’s Tomorrow: Looking at the Future and presented two posters: Accelerating drug development: data sharing and developing quantitative tools through the Duchenne Regulatory Science Consortium (D-RSC)...
• June 24, 2018
  

  Completing Patient-Reported Outcome Measures Electronically: A Review of the Literature on Subject Burden in Clinical Trials